Privigen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Comparison of the Safety, Pharmacokinetics and Pharmacodynamics of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines
Condition:   Human Rabies Interventions:   Biological: SYN023;   Biological: Imovax, human rabies immune globulin;   Biological: RabAvert, human rabies immune globulin Sponsors:   Synermore Biologics Co., Ltd.;   inVentiv Health Clinical Recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2016 Category: Research Source Type: clinical trials